MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 78 filers reported holding MUSTANG BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $14,282 | +114.7% | 38,956 | +131.3% | 0.00% | – |
| Q4 2022 | $6,651 | -91.6% | 16,843 | -87.5% | 0.00% | – |
| Q2 2022 | $79,000 | +393.8% | 134,607 | +748.2% | 0.00% | – |
| Q1 2022 | $16,000 | -95.6% | 15,870 | -92.8% | 0.00% | – |
| Q4 2021 | $364,000 | +30.5% | 219,864 | +111.5% | 0.00% | – |
| Q3 2021 | $279,000 | -59.3% | 103,967 | -49.6% | 0.00% | – |
| Q2 2021 | $686,000 | -9.0% | 206,455 | -9.1% | 0.00% | – |
| Q1 2021 | $754,000 | -71.0% | 227,085 | -67.0% | 0.00% | – |
| Q4 2020 | $2,602,000 | +183.4% | 687,300 | +135.7% | 0.00% | – |
| Q3 2020 | $918,000 | +110.1% | 291,597 | +112.2% | 0.00% | – |
| Q2 2020 | $437,000 | +131.2% | 137,425 | +94.7% | 0.00% | – |
| Q1 2020 | $189,000 | -56.7% | 70,571 | -33.9% | 0.00% | – |
| Q4 2019 | $436,000 | -1.1% | 106,700 | -21.1% | 0.00% | – |
| Q3 2019 | $441,000 | -62.9% | 135,274 | -58.1% | 0.00% | – |
| Q2 2019 | $1,188,000 | +37.7% | 322,548 | +309.0% | 0.00% | – |
| Q1 2018 | $863,000 | – | 78,859 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 224,192 | $706,000 | 1.53% |
| Endurant Capital Management LP | 1,423,050 | $4,483,000 | 1.33% |
| FNY Investment Advisers, LLC | 300,000 | $945,000 | 0.40% |
| Ikarian Capital, LLC | 806,475 | $2,541,000 | 0.18% |
| 683 Capital Management, LLC | 460,000 | $1,449,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 150,241 | $473,000 | 0.08% |
| ALGERT GLOBAL LLC | 61,440 | $194,000 | 0.06% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 85,000 | $268,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 164,577 | $518,000 | 0.03% |
| B. Riley Wealth Advisors, Inc. | 174,325 | $550,000 | 0.03% |